Kaposi's sarcoma is a public health concern in SSA. More studies appropriate to therapy for
Kaposi's sarcoma in resource-poor environments like SSA are imperative. We are hopeful …

Background: The optimal approach to HIV-associated Kaposi sarcoma (HIV-KS) in sub-
Saharan Africa is unknown. With large-scale rollout of highly active antiretroviral therapy …

Treatment strategies for Kaposi sarcoma in sub-Saharan Afric... : Current Opinion in Oncology
Treatment strategies for Kaposi sarcoma in sub-Saharan Africa: challenges and opportunities …

Abstract Background Kaposi's Sarcoma is the most common sarcoma and second most
prevalent cancer seen in Tanzania. Little is known about Kaposi's sarcoma in our setting as …

Introduction HIV‐associated Kaposi sarcoma (HIV‐KS) is the most common cancer in
Malawi. In 2008, the non‐governmental organization, Partners In Health, and the Ministry of …

Introduction The incidence of Kaposi sarcoma (KS) has increased dramatically among
women in sub-Saharan Africa since the onset of the HIV pandemic, but data on KS disease …

Human herpes virus 8 (HHV8) is the etiological agent of all forms of Kaposi's sarcoma (KS).
Six major subtypes (A‐F), based on genetic variability of open reading frame (ORF)‐K1 …

Background: HIV-associated Kaposi sarcoma (KS) is commonly staged using the AIDS
Clinical Trials Group criteria, which classify 3 variables—tumor extent (T), immune status (I) …

Background. When South Africa (SA) implemented its antiretroviral therapy (ART)
programme in 2004, the model for treating HIVpositive Kaposi's sarcoma (KS) patients …

Tanzania has high human immunodeficiency virus and human herpes virus-8 rates linked to
Kaposi's sarcoma. We conducted a study at the Ocean Road Cancer Institute in Dar es …